Price (delayed)
$78.74
Market cap
$98.2B
P/E Ratio
21.51
Dividend/share
$2.92
EPS
$3.66
Enterprise value
$118.02B
Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.